AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Biovalp 250mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Bioris Pharmaceuticals

Salt Composition

Divalproex (250mg)

Overview Biovalp 250mg Tablet ER

Epileptic seizures and migraine prevention are key uses for the extended-release Biovalp 250mg tablet. It's also sometimes prescribed for bipolar disorder management. Dosage and frequency are determined individually by your physician to optimize symptom control, and can be administered with or without food, but consistently at the same time daily for maximum effectiveness. Therapeutic effects typically emerge within a couple of weeks. Consistent use, as directed, is crucial; discontinuation or missed doses risk seizure recurrence and condition exacerbation; abrupt cessation is strongly discouraged. Common side effects, often mild, include nausea, vomiting, dizziness, fatigue, visual blurring, headaches, unsteady gait, easy bruising, and hypothermia. Consult your doctor if these persist or are bothersome, and immediately report any skin rash or redness. Long-term use may decrease bone density (osteoporosis), raising fracture risk. Rarely, suicidal ideation or behavior may occur; report any depressive mood changes promptly. Prior to commencing Biovalp, inform your physician of any pre-existing heart, kidney, liver conditions, urinary difficulties, depression, or suicidal tendencies. Potential drug interactions exist; disclose all medications currently being taken to ensure safe usage. Pregnancy necessitates consulting your physician before initiating or discontinuing treatment. Alcohol consumption should be avoided due to potential side effect amplification and increased seizure risk. Regular blood tests, pre- and post-treatment, are often necessary for optimal dose monitoring.

Uses of Biovalp 250mg Tablet ER

Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prophylaxis

Major Benefits of Biovalp 250mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Biovalp 250mg Extended-Release Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Biovalp 250mg ER Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Biovalp 250mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Biovalp 250mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 250mg Biovalp Extended-Release tablet whole; avoid chewing, crushing, or breaking it. While Biovalp 250mg ER can be administered with or without food, consistent timing is recommended.

How Biovalp 250mg Tablet ER works:

Epileptic seizures are managed by Biovalp 250mg Extended-Release Tablets, which reduce hyperactive neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Extended-release Biovalp 250mg tablets can induce pronounced sleepiness when combined with alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Biovalp 250mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Seek medical advice before use.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Biovalp 250mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release Biovalp 250mg tablets may impair driving ability due to potential adverse effects.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Biovalp 250mg tablets are considered safe for individuals with kidney impairment; no dosage modification is necessary.

LiverLiverUNSAFE

Extended-release Biovalp 250mg tablets are likely unsuitable for individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Biovalp 250mg Tablet ER :

Should you forget a Biovalp 250mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Biovalp 250mg Tablet ER

LabelValue
Type of Compound Fatty Acid Derivatives
Potential for Dependence None.
Type of Treatment Nervous system (brain and spinal cord)
Mechanism of Action Anticonvulsants that target sodium channels

FAQs on Biovalp 250mg Tablet ER

Discontinuing Biovalp 250mg Extended-Release Tablets requires prior consultation with your physician. The dosage should be tapered off gradually under medical guidance before complete cessation. Abrupt discontinuation may result in symptom reappearance, including irritability, anxiety, dizziness, and tremors.
Biovalp 250mg Extended-Release tablets may be employed in managing mood instability. Prescribing occurs for individuals exhibiting rapid mood fluctuations. The mechanism involves attenuating heightened brain activity associated with these shifts.
Biovalp 250mg Extended-Release tablets can lead to weight increase, potentially stemming from heightened appetite. Maintaining a balanced diet and regular physical activity can help mitigate this. Discuss any weight concerns with your physician.
Drowsiness is a potential side effect of Biovalp 250mg Extended-Release Tablets. Refrain from operating machinery or engaging in activities demanding concentration until you assess your response to the medication.
Biovalp 250mg Extended-Release tablets can induce temporary hair thinning, often linked to dosage. If this side effect concerns you or continues, seek medical advice.
Liver injury is a potential adverse effect of Biovalp 250mg Extended-Release tablets. This risk is heightened within the initial six months of treatment. Indicators of liver damage can manifest as nausea, vomiting, anorexia, abdominal pain, darkened urine, facial edema, and jaundice. Consequently, baseline liver function tests are recommended prior to commencing therapy, with subsequent monitoring during the first six months, particularly for at-risk individuals and those with a history of hepatic impairment.
Refrain from consuming alcohol during your Biovalp 250mg Tablet ER treatment course. Concurrent alcohol use may increase drowsiness, lightheadedness, or dizziness.
Prior to initiating Biovalp 250mg Tablet ER treatment, your physician might recommend preliminary bloodwork. This may encompass a complete blood count (including platelets), bleeding time assessment, and coagulation studies. These analyses help mitigate the risk of unexpected bleeding or bruising. Furthermore, pre-treatment liver function tests are advisable. Regular liver function monitoring is suggested during the initial six months of treatment, particularly for high-risk individuals and those with a history of liver conditions.
Intense stomach pain accompanied by nausea and vomiting could indicate pancreatitis. Seek immediate medical attention if you exhibit these symptoms. Your physician might order a serum amylase test; a positive result necessitates immediate discontinuation of the medication.
An excess of Biovalp 250mg Extended-Release tablets can lead to headaches, blurry vision from constricted pupils, diminished reflexes, disorientation, and fatigue. Further symptoms might include muscle weakness, convulsions, unconsciousness, altered behavior, and respiratory problems like rapid breathing, breathlessness, or chest discomfort. Seek immediate medical care if an overdose occurs.
Biovalp 250mg Tablet ER
80
MRP 98
18% off